Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-01 Sale | 2026-06-03 5:04 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 6,643 | $26.2 | $174,048 | 27,970 (Indirect) | View |
| 2026-06-01 Sale | 2026-06-03 5:01 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $25.66 | $381,112 | 207,554 (Direct) | View |
| 2026-05-29 Sale | 2026-06-02 4:12 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $26.34 | $197,554 | 61,451 (Direct) | View |
| 2026-05-22 Sale | 2026-05-27 4:16 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 32,564 | $26.01 | $847,048 | 350,987 (Indirect) | View |
| 2026-05-15 Sale | 2026-05-18 5:07 pm | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 1,938 | $26 | $50,388 | 31,001 (Indirect) | View |
| 2026-05-14 Sale | 2026-05-18 5:03 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $26.22 | $393,354 | 222,407 (Direct) | View |
| 2026-04-29 Sale | 2026-05-01 4:18 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $25.37 | $190,299 | 54,646 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 4:08 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $29.46 | $441,904 | 237,407 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 4:06 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 2,500 | $29.44 | $73,611 | 46,798 (Direct) | View |
| 2026-03-30 Sale | 2026-04-01 4:12 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $29.34 | $220,019 | 62,146 (Direct) | View |
| 2026-03-20 Sale | 2026-03-20 6:50 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $49.1 | $736,439 | 252,407 (Direct) | View |
| 2026-03-10 Sale | 2026-03-12 4:51 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 30,000 | $50.45 | $1,513,560 | 267,407 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:25 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $45.43 | $340,723 | 126,646 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:20 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $45.2 | $226,011 | 97,298 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:25 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $46.02 | $690,334 | 297,407 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 4:23 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $46.04 | $230,219 | 57,323 (Direct) | View |
| 2026-01-29 Sale | 2026-02-02 4:21 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $44.27 | $331,990 | 77,146 (Direct) | View |
| 2026-01-22 Sale | 2026-01-26 4:10 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $45.52 | $227,612 | 21,320 (Direct) | View |
| 2026-01-07 Sale | 2026-01-09 4:51 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $40.2 | $1,011,299 | 312,407 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:30 pm | Maze Therapeutics Inc. | MAZE | Sohn Catherine A. Director | 29,413 | $39.07 | $1,149,054 | 9,332 (Direct) | View |
| 2026-01-02 Sale | 2026-01-06 4:31 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $40.39 | $195,668 | 675,538 (Direct) | View |
| 2026-01-02 Sale | 2026-01-06 4:30 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $39.15 | $195,754 | 18,325 (Direct) | View |
| 2025-12-29 Sale | 2025-12-31 4:24 pm | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 72,500 | $40.56 | $2,940,799 | 158,889 (Direct) | View |
| 2025-12-29 Sale | 2025-12-31 4:22 pm | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $40.56 | $1,825,355 | 342,407 (Direct) | View |
| 2025-12-29 Sale | 2025-12-31 4:20 pm | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 15,000 | $40.41 | $606,173 | 41,777 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-08 Option Award | 2026-06-10 4:31 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | SPIEGELMAN DANIEL K Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:30 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | SCHELLER RICHARD H Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:28 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Lim Jonathan E Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:26 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Hoppenot Herve Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:25 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-08 Option Award | 2026-06-10 4:23 pm | N/A 2036-06-07 | Maze Therapeutics Inc. | MAZE | Andrews Nancy C Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 5:01 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $10.42 | 207,554 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 5:01 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 14,853 | $0 | 207,554 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-02 4:12 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 61,451 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-02 4:12 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 61,451 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 5:03 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 222,407 (Direct) | View |
| 2026-05-14 Exercise | 2026-05-18 5:03 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 222,407 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 4:15 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 14,305 | $10.42 | 72,737 (Direct) | View |
| 2026-05-04 Exercise | 2026-05-06 4:15 pm | N/A 2032-03-15 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 14,305 | $0 | 72,737 (Direct) | View |
| 2026-05-04 Gift | 2026-05-06 4:13 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 7,422 | $0 | 31,113 (Direct) | View |
| 2026-04-29 Exercise | 2026-05-01 4:18 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 54,646 (Direct) | View |
| 2026-04-29 Exercise | 2026-05-01 4:18 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 54,646 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:08 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 237,407 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:08 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 237,407 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:06 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 2,500 | $10.42 | 46,798 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 4:06 pm | N/A 2034-12-08 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 2,500 | $0 | 46,798 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 4:12 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 62,146 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 4:12 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 62,146 (Direct) | View |
| 2026-03-27 Option Award | 2026-03-31 4:13 pm | N/A 2036-03-26 | Maze Therapeutics Inc. | MAZE | Kumar Neil Director | 33,417 | $0 | 33,417 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-20 6:50 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 252,407 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-20 6:50 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 252,407 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:51 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 30,000 | $10.42 | 267,407 (Direct) | View |
| 2026-03-10 Exercise | 2026-03-12 4:51 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 30,000 | $0 | 267,407 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:30 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Tahir Misbah Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:28 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Courtney Phillips GC and Corp. Secretary | 48,000 | $0 | 48,000 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:25 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 57,000 | $0 | 126,646 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-03 4:25 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 126,646 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-03 4:25 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 126,646 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:23 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 72,000 | $0 | 72,000 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:20 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 48,000 | $0 | 97,298 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-03 4:20 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $10.42 | 97,298 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-03 4:20 pm | N/A 2034-12-08 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $0 | 97,298 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-03 4:17 pm | N/A 2036-03-01 | Maze Therapeutics Inc. | MAZE | Coloma Jason V Chief Executive Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-04 4:25 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $10.42 | 297,407 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-04 4:25 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 15,000 | $0 | 297,407 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-04 4:23 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $10.42 | 57,323 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-04 4:23 pm | N/A 2032-02-17 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $0 | 57,323 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:21 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $10.42 | 77,146 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:21 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 7,500 | $0 | 77,146 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 4:10 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $10.42 | 21,320 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 4:10 pm | N/A 2031-03-03 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $0 | 21,320 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 4:51 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $10.42 | 312,407 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 4:51 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 25,156 | $0 | 312,407 (Direct) | View |
| 2026-01-06 Exercise | 2026-01-08 4:30 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Sohn Catherine A. Director | 29,413 | $10.42 | 9,332 (Direct) | View |
| 2026-01-06 Exercise | 2026-01-08 4:30 pm | N/A 2033-03-08 | Maze Therapeutics Inc. | MAZE | Sohn Catherine A. Director | 29,413 | $0 | 9,332 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:31 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $10.42 | 675,538 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:31 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 4,844 | $0 | 675,538 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:30 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $10.42 | 18,325 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 4:30 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 5,000 | $0 | 18,325 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:24 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 72,500 | $10.42 | 158,889 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:24 pm | N/A 2031-04-11 | Maze Therapeutics Inc. | MAZE | Dandekar Atul CSBO | 72,500 | $0 | 158,889 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:22 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $10.42 | 342,407 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:22 pm | N/A 2032-10-26 | Maze Therapeutics Inc. | MAZE | Bernstein Harold President, R&D & CMO | 45,000 | $0 | 342,407 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:20 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 15,000 | $10.42 | 41,777 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-31 4:20 pm | N/A 2031-02-01 | Maze Therapeutics Inc. | MAZE | Bachrodt Amy SVP, Finance | 15,000 | $0 | 41,777 (Direct) | View |
| 2025-11-19 Other | 2025-11-21 4:24 pm | N/A N/A | Maze Therapeutics Inc. | MAZE | HOMCY CHARLES J Director | 1,489 | $0 | 40,024 (Direct) | View |